Embla Medical hf: Conference call details for Q3 2025
Börskollen - Aktier, fonder och ekonominyheter
BörskollenFör dig med koll på börsen

Pressmeddelande

Embla Medical hf: Conference call details for Q3 2025

Reykjavik, Iceland/Copenhagen, Denmark, 3 October 2025. Embla Medical (Nasdaq Copenhagen: EMBLA) will publish its Q3 2025 Report on 21 October 2025 at 7:00 CET. A conference call will be hosted on the same day at 9:00 CET / 7:00 GMT / 3:00am EST.

The event will be hosted by Sveinn Solvason, President and CEO, and G. Arna Sveinsdottir, CFO. The call will include a review of the quarterly results and will be held in English.

Slides used in the presentation will be made available on the company website at the following link: https://www.emblamedical.com/investors

To participate in the telephone conference, please use the dial-in details provided below:

DK: +45 78 76 84 90

SE: +46 31-311 50 03

UK: +44 20 3769 6819

US: +1 646 787 0157

Participant access code: 274982

The webcast will be available through following link:  Embla Medical Q3 2025 webcast

Financial calendar and events 2025/2026

21 Oct 2025                    Interim Report Q3 2025

21 Oct 2025                    Q3 2025 HCA Capital virtual presentation and Q&A

21 Oct 2025                    Q3 2025 Investor Road Show Copenhagen (Danske Bank)

22-23 Oct 2025             Q3 2025 Investor Road Show Benelux (DNB Carnegie)

23 Oct 2025                   Q3 2025 Investor Road Show New York City (DNB Carnegie)

4 Nov 2025                     Berenberg Nordic Seminar, Frankfurt               

17 Nov 2025                   InvestorDagen Dansk Aktionærforening, Copenhagen

19-20 Nov 2025             Jefferies Global Healthcare Conference, London

24 Nov 2025                   AktieInfo Investor Event (Retail), Aalborg

25 Nov 2025                   DNB Carnegie Healthcare conference

26 Nov 2025                  Danske Bank Winter Seminar, Copenhagen

2 Dec 2025                     Nordea Focus Seminar, Paris

8 Jan 2025                      SEB Nordic Seminar, Copenhagen

3 Feb 2025                     Interim Report Q4 2025 & 2025 Annual Report

If you wish to receive Embla Medical press releases by e-mail, please register here

For further information please contact

Klaus Sindahl

Head of Investor Relations

M: +45 5363 0134

E: [email protected]

About Embla Medical

Embla Medical (Nasdaq Copenhagen: EMBLA) is a leading global provider of innovative mobility solutions that help people live a Life Without Limitations®. Home to several leading brands, Embla Medical is dedicated to improving people‘s mobility by providing prosthetics, neuro orthotics, bracing & supports and patient care through a global network of orthotic & prosthetic facilities. Embla Medical is committed to sustainable business practices renowned for positively impacting people‘s health and well-being.

Nyheter om Embla Medical

Läses av andra just nu

Om aktien Embla Medical

Senaste nytt